Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
41.90
+0.45 (1.09%)
Feb 3, 2026, 3:00 PM CST

SHA:600211 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,7142,8003,1282,5452,1271,362
Other Revenue
6.736.736.249.6912.0611.49
2,7212,8073,1342,5552,1391,373
Revenue Growth (YoY)
-7.52%-10.45%22.69%19.45%55.75%9.32%
Cost of Revenue
182.68162.1158.67204.74225.8195.69
Gross Profit
2,5382,6452,9762,3501,9131,177
Selling, General & Admin
1,5961,6851,8811,5411,254747.78
Research & Development
40.0328.9417.3588.1360.867.46
Other Operating Expenses
96.6737.138.1732.5426.214.47
Operating Expenses
1,7341,7511,9371,6621,340770.09
Operating Income
804.18893.441,039688.27572.75407.32
Interest Expense
-2.46-9.48-11.59-14.36-4.33-1.05
Interest & Investment Income
81.7974.3886.2221.352.6711.43
Currency Exchange Gain (Loss)
-2.47-2.47-0.11-3.83-4.783.29
Other Non Operating Income (Expenses)
2.72-0.17-0.47-0.39-0.35-0.26
EBT Excluding Unusual Items
883.76955.691,113691.03565.96420.73
Gain (Loss) on Sale of Investments
-15.37-18.99-210.53-14.17146.470.95
Gain (Loss) on Sale of Assets
-0.161.90.34-0.23-0.17-0.03
Asset Writedown
-0.57--190.38-218.62-458.06-
Other Unusual Items
212.05213.48186.035.360.6448.66
Pretax Income
1,0801,152898.19463.39254.85470.32
Income Tax Expense
91.8895.0187.9588.0841.8249.65
Earnings From Continuing Operations
987.841,057810.24375.31213.03420.66
Minority Interest in Earnings
-6.64-5.79-9.33-5.47-4.09-2.57
Net Income
981.21,051800.91369.84208.94418.1
Net Income to Common
981.21,051800.91369.84208.94418.1
Net Income Growth
33.05%31.26%116.56%77.01%-50.03%33.87%
Shares Outstanding (Basic)
323322323323323322
Shares Outstanding (Diluted)
323322323323323322
Shares Change (YoY)
0.13%-0.14%0.09%-0.21%0.53%-0.98%
EPS (Basic)
3.043.262.481.150.651.30
EPS (Diluted)
3.043.262.481.150.651.30
EPS Growth
32.88%31.45%116.37%77.38%-50.29%35.19%
Free Cash Flow
925.89957.191,042735.41-59.05206.87
Free Cash Flow Per Share
2.872.973.232.28-0.180.64
Dividend Per Share
0.7281.9571.4920.5740.2600.392
Dividend Growth
-59.46%31.21%159.93%120.69%-33.72%-32.64%
Gross Margin
93.28%94.23%94.94%91.98%89.44%85.75%
Operating Margin
29.56%31.83%33.14%26.94%26.78%29.66%
Profit Margin
36.07%37.46%25.55%14.48%9.77%30.45%
Free Cash Flow Margin
34.03%34.10%33.24%28.79%-2.76%15.07%
EBITDA
883967.641,107757.52654.2484.95
EBITDA Margin
32.46%34.48%35.31%29.65%30.59%35.32%
D&A For EBITDA
78.8274.268.0569.2481.4577.63
EBIT
804.18893.441,039688.27572.75407.32
EBIT Margin
29.56%31.83%33.14%26.94%26.78%29.66%
Effective Tax Rate
8.51%8.25%9.79%19.01%16.41%10.56%
Revenue as Reported
---2,5552,1391,373
Advertising Expenses
-6.232.220.050.240.42
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.